|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fritzmann J, Morkel M, Besser D, Budczies
J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM and
Birchmeier W: A colorectal cancer expression profile that includes
transforming growth factor inhibitor BAMBI predicts metastatic
potential. Gastroenterology. 137:165–175. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Heinsbroek SE, Squadrito ML, Schilderink
R, Hilbers FW, Verseijden C, Hofmann M, Helmke A, Boon L,
Wildenberg ME, Roelofs JJ, et al: MiR-511-3p, embedded in the
macrophage mannose receptor gene, contributes to intestinal
inflammation. Mucosal Immunol. 9:960–973. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Akbari A, Ghahremani MH, Mobini GR,
Abastabar M, Akhtari J, Bolhassani M and Heidari M: Down-regulation
of miR-135b in colon adenocarcinoma induced by a TGF-β receptor I
kinase inhibitor (SD-208). Ran J Basic Med Sci. 18:856–861.
2015.
|
|
7
|
Wang XM, Zhang SF, Cheng ZQ, Peng QZ, Hu
JT, Gao LK, Xu J, Jin HT and Liu HY: MicroRNA-383 regulates
expression of PRDX3 in human medulloblastomas. Zhonghua Bing Li Xue
Za Zhi. 41:547–552. 2012.(In Chinese). PubMed/NCBI
|
|
8
|
Zhao L, Gu H, Chang J, Wu J, Wang D, Chen
S, Yang X and Qian B: MicroRNA-383 regulates the apoptosis of tumor
cells through targeting Gadd45g. PLoS One. 9:e1104722014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen L, Guan H, Gu C, Cao Y, Shao J and
Wang F: miR-383 inhibits hepatocellular carcinoma cell
proliferation via targeting APRIL. Tumour Boil. 37:2497–2507. 2016.
View Article : Google Scholar
|
|
10
|
Hahne M, Kataoka T, Schröter M, Hofmann K,
Irmler M, Bodmer JL, Schneider P, Bornand T, Holler N, French LE,
et al: APRIL, a new ligand of the tumor necrosis factor family,
stimulates tumor cell growth, stimulates tumor cell growth. J Exp
Med. 188:1185–1190. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mhawech-Fauceglia P, Kaya G, Sauter G,
McKee T, Donze O, Schwaller J and Huard B: The source of APRIL
up-regulation in human solid tumor lesions. J Leukoc Biol.
80:697–704. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mhawech-Fauceglia P, Allal A, Odunsi K,
Andrews C, Herrmann FR and Huard B: Role of the tumour necrosis
family ligand APRIL in solid tumour development: Retrospective
studies in bladder, ovarian and head and neck carcinomas. Eur J
Cancer. 44:2097–2100. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lascano V, Zabalegui LF, Cameron K,
Guadagnoli M, Jansen M, Burggraaf M, Versloot M, Rodermond H, van
der Loos C, Carvalho-Pinto CE, et al: The TNF family member APRIL
promotes colorectal tumorigenesis. Cell Death Differ. 19:1826–1835.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang GH, Lu MH, Wang JC, Wang F, Ding WF,
Wang YG, Ju SQ and Wang HM: Abnormal expression of APRIL in
colorectal cancer cells promotes tumor growth and metastasis.
Zhonghua Zhong Liu Za Zhi. 35:249–255. 2013.(In Chinese).
PubMed/NCBI
|
|
15
|
Ding W, Wang J, Sun B, Ju S, Yuan H, Wang
X, Wang Y and Wang H: APRIL knockdown suppress migration and
invasion of human colon caner cells. Clin Biochem. 42:1694–1698.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhan J, Liu JP, Zhu ZH, Yao HR and Chen
CY: Relationship between COX-2 expression and clinicopathological
features of colorectal cancers. Chin Med J. 117:1151–1154.
2004.PubMed/NCBI
|
|
17
|
Basu GD, Liang WS, Stephan DA, Wegener LT,
Conley CR, Pockaj BA and Mukherjee P: A novel role for
cyclooxygenase-2 in regulating vascular channel formation by human
breast cancer cells. Breast Cancer Res. 8:R692006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tsujli M, Kawano S, Tsuji S, Swaoka H,
Hori M and DuBois RN: Cyclooxygenase regulates angiogenesis induced
by colon cancer cells. Cell. 93:705–716. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Akgul C: Mcl-1is a potential therapeutic
target in multiple types of cancer. Cell Mol Life Sci.
66:1326–1336. 2008. View Article : Google Scholar
|
|
20
|
Ma XT, Yu LW, Wang S, Du RY and Cui ZR:
Molecular mechanism of Stat5b signaling pathway in regulating the
expression of bcl-2 family members and promoting survival of human
colon cancer cells. Zhonghua Shi Yan Wai Ke Za Zhi. 22:1157–1169.
2005.(In Chinese).
|
|
21
|
Yoon JH, Werneburg NW, Higuchi H, Canbay
AE, Kaufmann SH, Akgul C, Edwards SW and Gores GJ: Bile acids
inhibit Mcl-1 protein turnover via an epidermal growth factor
receptor/Raf-1-dependent mechanism. Cancer Res. 62:6500–6505.
2002.PubMed/NCBI
|
|
22
|
Fan G, Jiang X, Wu X, Fordjour PA, Miao L,
Zhang H, Zhu Y and Gao X: Anti-Inflammatory Activity of Tanshinone
IIA in LPS-Stimulated RAW264.7 Macrophages via miRNAs and
TLR4-NF-κB pathway. Inflammation. 39:375–384. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liao XH, Zheng L, He HP, Zheng DL, Wei ZQ,
Wang N, Dong J, Ma WJ and Zhang TC: STAT3 regulated ATR via
microRNA-383 to control DNA damage to affect apoptosis in A431
cells. Cell Signal. 27:2285–2295. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sobin LH and Fleming ID: TNM
classification of malignant tumors, fifth edition (1997). Union
Internationale Contre le Cancer and the American Joint Committee on
Cancer. Cancer. 80:1803–1804. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancer. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Orellana EA and Kasinski AL: MicroRNAs in
cancer: A historical perspective on the path from discovery to
therapy. Cancers (Basel). 7:1388–1405. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li C, Wang Y, Lu S, Zhang Z, Meng H, Liang
L, Zhang Y and Song B: MiR-34a inhibits colon cancer proliferation
and metastasis by inhibiting platelet-derived growth factor
receptor α. Mol Med Rep. 12:7072–7078. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liang Y, Zhao Q, Fan L, Zhang Z, Tan B,
Liu Y and Li Y: Down-regulation of microRNA-381 promotes cell
proliferation and invasion in colon cancer through up-regulation of
LRH-1. Biomed Pharmacother. 75:137–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Roosnek E, Burjanadze M, Dietrich PY,
Matthes T, Passweg J and Huard B: Tumors that look for their
springtime in APRIL. Crit Rev Oncol Hematol. 72:91–97. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang G, Wang F, Ding W, Wang X, Xu J, Li H
and Wang H: APRIL mediates migration and invasion of colorectal
cancer cell via regulation of matrix metalloproteinases. Chin J
Microbiol Immunol. 32:128–133. 2012.(In Chinese).
|
